OYST
Oyster Point Pharma, Inc. Common Stock
OYST
OYST
Delisted
OYST was delisted on the 30th of December, 2022.
69 hedge funds and large institutions have $211M invested in Oyster Point Pharma, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
34% less capital invested
Capital invested by funds: $318M → $211M (-$108M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $207K
Holders
69
Holding in Top 10
2
Calls
–
Puts
$207K
Top Buyers
| 1 | +$5.92M | |
| 2 | +$1.33M | |
| 3 | +$1.08M | |
| 4 |
First Manhattan
New York
|
+$867K |
| 5 |
HSBC Holdings
London,
United Kingdom
|
+$790K |
Top Sellers
| 1 | -$21.5M | |
| 2 | -$658K | |
| 3 | -$320K | |
| 4 |
VVA
Vida Ventures Advisors
Boston,
Massachusetts
|
-$218K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$180K |